Publicaciones en colaboración con investigadores/as de Hospital Costa Del Sol (41)

2023

  1. Clinical and Ecological Impact of an Educational Program to Optimize Antibiotic Treatments in Nursing Homes (PROA-SENIOR): A Cluster, Randomized, Controlled Trial and Interrupted Time-Series Analysis

    Clinical Infectious Diseases, Vol. 76, Núm. 5, pp. 824-832

  2. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  3. Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Anales de Pediatria, Vol. 98, Núm. 3, pp. 213-227

  4. Executive summary – Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Atencion Primaria, Vol. 55, Núm. 6

  5. Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 111-122

  6. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  7. Projected clinical benefits of dapagliflozin in patients with heart failure with preserved ejection fraction

    Future cardiology, Vol. 19, Núm. 6, pp. 333-342

  8. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

    Journal of Medical Virology, Vol. 95, Núm. 12

2019

  1. Prevalence and outcome of diuretic resistance in heart failure

    Internal and Emergency Medicine, Vol. 14, Núm. 4, pp. 529-537

  2. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

  3. Safety and efficacy of prolonged use of dalbavancin in bone and joint infections

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5